Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Adrien Costantini, Marta Grynovska, Francesca Lucibello, Jorge Moisés, Franck Pagès, Ming S. Tsao, Frances A. Shepherd, Hasna Bouchaab, Marina Garassino, Joachim G.J.V. Aerts, Julien Mazières, Michele Mondini, Thierry Berghmans, Anne-Pascale Meert, Jacques Cadranel. Immunotherapy: a new standard of care in thoracic malignancies?. Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017

Member's Comments

No comment yet.

Related content which might interest you: Quality management in thoracic oncology: how do patients and clinicians benefit? Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe Year: 2012 Improving tumour documentation in thoracic oncology: what can we learn from each other? Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe Year: 2012 Multidisciplinary team management in thoracic oncology: more than just a concept? Source: Eur Respir J 2014; 43: 1776-1786 Year: 2014 Palliative care or standard chemotherapy in lung cancer patients? Source: Annual Congress 2012 - Ethics Grand Round: an interactive session Year: 2012 Integrated care approaches in palliative care in thoracic malignancies Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Supportive care and local palliation for thoracic malignancies Source: Annual Congress 2008 - PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer) Year: 2008 Multidisciplinary mesothelioma treatment: practical aspects including palliative care Source: Annual Congress 2009 - MP10 - Multidisciplinary mesothelioma treatment: practical aspects including palliative care Year: 2009 NIMV application in oncology: palliative treatment or new frontline? Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 Single-institution experience of the combined operations in management of lung cancer: Lessons learned Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 Checkpointinhibition in lung cancer – already standard of care in any line of therapy?  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017 Perioperative systemic therapy in resectable lung cancer: from standard operating procedures to immuno-oncology and back Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Rationale and targets of immunotherapy in thoracic malignancies Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Challenges and controversies in thoracic oncology: a new ERJ series Source: Eur Respir J 2014; 43: 1571-1572 Year: 2014 Clinical nurse specialist led image guided pleural interventions – Is it safe? Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 What is the best oncological management strategy for mesothelioma in 2018? Source: International Congress 2018 – Malignant pleural effusions Year: 2018 Palliative care in thoracic oncology Source: Breathe 2012; 9: 124-131 Year: 2012